Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.52 USD | -2.70% | -4.91% | -82.01% |
May. 24 | Top Midday Decliners | MT |
May. 24 | Genelux Prices $27.5 Million Securities Offering at $4 a Share; Shares Drop | MT |
Business Summary
Number of employees: 23
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Diagnostic and Therapeutic Solutions
100.0
%
| 11 | 100.0 % | 0 | 100.0 % | -98.46% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 11 | 100.0 % | 0 | 100.0 % | -98.46% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Thomas Zindrick
CEO | Chief Executive Officer | 65 | 09-12-31 |
Lourie Zak
DFI | Director of Finance/CFO | 61 | 23-08-27 |
Paul Scigalla
CTO | Chief Tech/Sci/R&D Officer | 79 | 11-08-31 |
Joseph Cappello
CTO | Chief Tech/Sci/R&D Officer | 67 | 12-10-31 |
Caroline Jewett
PRN | Corporate Officer/Principal | 59 | 23-07-19 |
Sean Ryder
LAW | General Counsel | 54 | 21-09-30 |
Qian Zhang
PRN | Corporate Officer/Principal | 60 | 02-12-31 |
Tony Yu
PRN | Corporate Officer/Principal | 53 | 01-12-31 |
Ralph Smalling
LAW | General Counsel | 68 | 23-07-19 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
James Tyree
BRD | Director/Board Member | 71 | 12-05-01 |
John Thomas
BRD | Director/Board Member | 66 | 02-08-31 |
John Smither
BRD | Director/Board Member | 71 | 23-09-10 |
Thomas Zindrick
CEO | Chief Executive Officer | 65 | 09-12-31 |
Mary Mirabelli
BRD | Director/Board Member | 67 | 21-05-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 34,305,073 | 27,938,205 ( 81.44 %) | 433,333 ( 1.263 %) | 81.44 % |
Company contact information
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-82.01% | 88.22M | |
+19.33% | 125B | |
+13.95% | 109B | |
-3.53% | 24.74B | |
+2.71% | 22.67B | |
-9.95% | 18.14B | |
-41.48% | 16.67B | |
-12.62% | 16.64B | |
+0.99% | 13.45B | |
+21.79% | 11.32B |
- Stock Market
- Equities
- GNLX Stock
- Company Genelux Corporation